IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Imunon, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 11, 2026
$0.98−0.04 (-3.43%)
Close on Oct 19, 2026
- Market cap
- $4.95M
- P/E (TTM)
- –
- Dividend yield
- –
Imunon statistics
Financials through Mar 31, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Imunon | Industry median |
|---|---|---|
| Market Cap | $5.53M | $166.30M |
| Enterprise Value | $727.23K | $88.19M |
| PB Ratio | 1.65 | 2.03 |
| P/TBV Ratio | 1.65 | 2.29 |
Income (trailing twelve months)
| Measure | Imunon | Industry median |
|---|---|---|
| Operating Income | -$14.81M | -$21.40M |
| Net Income | -$14.64M | -$22.46M |
| EBITDA | -$14.81M | -$16.91M |
| EPS (Diluted) | -$5.59 | -$0.83 |
Returns
| Measure | Imunon | Industry median |
|---|---|---|
| Return on Equity (ROE) | -768.3% | -53.2% |
| Return on Assets (ROA) | -196.8% | -40.9% |
| Return on Capital Employed (ROCE) | -384.5% | -38.1% |
Balance sheet
| Measure | Imunon | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.80M | $61.43M |
| Net Cash (Debt) | $4.80M | $15.35M |
| Net Cash Per Share | $0.86 | $0.66 |
| Equity (Book Value) | $3.36M | $49.09M |
| Book Value Per Share | $0.60 | $1.37 |
| Tangible Book Value | $3.36M | $23.52M |
| Working Capital | $2.45M | $76.81M |
Financial position
| Measure | Imunon | Industry median |
|---|---|---|
| Current Ratio | 1.59 | 3.34 |
| Quick Ratio | 1.15 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Imunon | Industry median |
|---|---|---|
| Operating Cash Flow | -$15.03M | -$12.35M |
Efficiency
| Measure | Imunon | Industry median |
|---|---|---|
| Profits Per Employee | -$732.08K | -$703.34K |
| Employee Count | 20 | 74 |
Dividends and yields
| Measure | Imunon | Industry median |
|---|---|---|
| Earnings Yield | -264.9% | -23.3% |
Shares
| Measure | Imunon | Industry median |
|---|---|---|
| Shares Outstanding | 5,611,400 | 58,127,000 |
| Shares Change (YoY) | 169.3% | 10.9% |
| Shares Change (QoQ) | 14.7% | 0.54% |
| Float | 5,241,730 | 49,136,700 |
| Shares Held by Insiders | 6.59% | 11.6% |
| Shares Held by Institutions | 5.68% | 59.4% |
Scores
| Measure | Imunon | Industry median |
|---|---|---|
| Altman Z-Score | -79.31 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Imunon's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.